ftInvstr
ANTHEM · Healthcare ₹934.95 -1.15% Mkt Cap ₹52613 Cr

ANTHEM

Healthcare Biotechnology
₹934.95
-1.15% today · 30d +13.07%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for ANTHEM. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹418 Cr
-22.58% YoY
NET PROFIT
₹120 Cr
-11.67% YoY
OPM
39.6%
+1.53pp YoY
EPS
₹2.13
PE 92.52
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-1.7%, h2=+5.3%, h3=-9.4% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
ANTHEM92.5230.0
BIOCON154.516.88
ONESOURCE5.79
CONCORDBIO57.4529.73
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
71
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 75
Valuation STRETCHED 20
Growth STRONG 74
Profitability HIGH 95
Technicals STRONG 70
Risk LOW 90
Key Stats
TTM PE
92.52
P/B
17.23
52W HIGH
₹973.5
OFF HIGH
-3.96%
DIV YIELD
0.21%
MKT CAP
₹52613 Cr
◉ Active Signals
MACDBullish1.7417
RSI(14)Bullish66.11
Near 52W HighBullish-3.96
Street Consensus
8 analysts
₹905.12
mean target
Low ₹830.0Now ₹934.95High ₹1050.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold ANTHEM and at what entry.

Sign up freeSign in